MMP9 and systemic sclerosis: Increased MMP9 production was found in SSc patient dermal fibroblasts, positively correlating with the extent of SSc skin pathology (Kim et al., 2005) and likely due to MMP9 activities independent of ECM degradation, including regulation of inflammatory cytokines and growth factors (Van Den Steen et al., 2002).